Author Question: You have won a contest and are allowed to choose between two prizes. One prize is 200 today and ... (Read 76 times)

MirandaLo

  • Hero Member
  • *****
  • Posts: 538
You have won a contest and are allowed to choose between two prizes. One prize is 200 today and another 200 one year from now. The other prize is 100 today and an additional 325 one year from now.
 
  At what interest rate (if any) would you be indifferent between the two prizes?

Question 2

Refer to Scenario 10.2. What is the profit maximizing level of output?
 
  A) 0
  B) 90
  C) 95
  D) 100
  E) none of the above



lgoldst9

  • Sr. Member
  • ****
  • Posts: 372
Answer to Question 1

Prize 1 has PDV = 200 + 200/(I + R)
Prize 2 has PDV = 100 + 365/(I + R)
Equating the PDV for prize 1 and prize 2 and solving for R yields:
200 + 200/(l + R) = 100 + 365/(l + R)
R = 0.25

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library